Brief: Herantis Pharma: Antti Vuolanto Appointed CEO
July 8 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* ANTTI VUOLANTO APPOINTED AS CEO OF HERANTIS AS OF 22 JULY
2022
* FRANS WUITE WILL CONTINUE AS INTERIM CEO OF HERANTIS
PHARMA PLC
UNTIL 21 JULY 2022 AND AS MEMBER OF BOARD ALSO THEREAFTER
Source text for Eikon: ID:nWkr2rwlfR
Further company coverage: HRTIS.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))